|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-31
|
|
pubmed:abstractText |
To assess the ability of combined whole-prostate magnetic resonance imaging and magnetic resonance spectroscopy imaging (MRI+MRSI) to predict the presence or absence of high grade (Gleason 4+3 or higher) prostate carcinoma in men with elevated PSA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1872-7727
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
340-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19740617-Adult,
pubmed-meshheading:19740617-Aged,
pubmed-meshheading:19740617-Aged, 80 and over,
pubmed-meshheading:19740617-Belgium,
pubmed-meshheading:19740617-Humans,
pubmed-meshheading:19740617-Magnetic Resonance Imaging,
pubmed-meshheading:19740617-Magnetic Resonance Spectroscopy,
pubmed-meshheading:19740617-Male,
pubmed-meshheading:19740617-Middle Aged,
pubmed-meshheading:19740617-Prevalence,
pubmed-meshheading:19740617-Prostate-Specific Antigen,
pubmed-meshheading:19740617-Prostatic Neoplasms,
pubmed-meshheading:19740617-Reproducibility of Results,
pubmed-meshheading:19740617-Risk Assessment,
pubmed-meshheading:19740617-Risk Factors,
pubmed-meshheading:19740617-Sensitivity and Specificity,
pubmed-meshheading:19740617-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients.
|
|
pubmed:affiliation |
Department of Radiology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. Geert.Villeirs@UGent.be
|
|
pubmed:publicationType |
Journal Article
|
